4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-046907
General Counsel sold 1,383 shares at an average $0.75 ($1,038)
From the SEC's structured data for this filing
Trades in this filing
Miller Edward · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-19 | Sale : show line 1 in the form | −626 | $0.75 | $470 | 223,984 | D |
| 2024-04-22 | Sale : show line 2 in the form | −757 | $0.75 | $568 | 223,227 | D |
| Open-market sales · 1,383 sh · avg $0.75 · $1,038 | ||||||
Loading xslF345X05/ownership.xml…